ENZO BIOCHEM INC (ENZ)

Tuesday's pre-market session: top gainers and losers

Get insights into the top gainers and losers of Tuesday's pre-market session.

Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update

FARMINGDALE, N.Y., March 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the second quarter ended January 31, 2024.

Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments

Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments

FARMINGDALE, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading life science company, announced...

ENZ Stock Earnings: Enzo Biochem Reported Results for Q1 2024

Enzo Biochem just reported results for the first quarter of 2024.

ENZ Stock Earnings: Enzo Biochem Reported Results for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Enzo Biochem (NYSE:ENZ) just reported results for the first quarter of 2024.Enz...

ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE

ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE

FARMINGDALE, NY, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the...

ENZO BIOCHEM REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS AND PROVIDES BUSINESS UPDATE

Steven J. Pully Appointed to Enzo Biochem’s Board of Directors

Steven J. Pully Appointed to Enzo Biochem’s Board of Directors

FARMINGDALE, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) --  Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “the Company”), a leading life sciences company, announced...

Enzo Biochem names interim CEO (NYSE:ENZ)

Enzo Biochem (ENZ) said Wednesday that its CEO Hamid Erfanian, has stepped down and that Chief Operating Officer Kara Cannon will become interim CEO. Read more here.

Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO

Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO

FARMINGDALE, NY, Sept. 06, 2023 (GLOBE NEWSWIRE) --  Enzo Biochem, Inc. (NYSE: ENZ) announced today that Hamid Erfanian, Chief Executive Officer (CEO),...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

It's time for another dive into the biggest pre-market stock movers as we check out the most recent news for Tuesday morning!

Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp

Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp

Significant value unlocked for Enzo shareholders with continued focus on life sciences. FARMINGDALE, NY, July 24, 2023 (GLOBE NEWSWIRE) -- Enzo...

Enzo Biochem Reports Third Quarter Fiscal Year 2023 Financial Results

Enzo Biochem Reports Third Quarter Fiscal Year 2023 Financial Results

- Enzo Life Sciences reports revenue of $7.5 million, with margin improvement in Q3 FY23 FARMINGDALE, NY, June 14, 2023 (GLOBE NEWSWIRE) -- Enzo...

Federman & Sherwood Investigates Enzo Biochem for Data Breach

Enzo Biochem files for $150M mixed shelf offering (NYSE:ENZ)

Enzo Biochem (ENZ) has filed for a $150M mixed shelf securities offering. Read more here.

Enzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset Sale

Enzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset Sale

FARMINGDALE, NY, May 22, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), announced today that  the preliminary voting results from the Inspector...

Friday Sector Leaders: Diagnostics, Drugs

SHAREHOLDER ALERT: Weiss Law Investigates Enzo Biochem, Inc.

/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Enzo Biochem, Inc....

Enzo Biochem, Inc. Announces Date of Special Meeting of Shareholders

Enzo Biochem, Inc. Announces Date of Special Meeting of Shareholders

FARMINGDALE, NY, April 24, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo Biochem” or the “Company”), a leading biosciences and...

Enzo Biochem stock slips after ransomware attack (NYSE:ENZ)

Enzo Biochem (ENZ) shed ~2% pre-market Friday after announcing a ransomware attack that has compromised the company’s IT systems leading to a data leak. Read more here.

Enzo Biochem Reports Second Quarter Fiscal Year 2023 Financial Results

Enzo Biochem Reports Second Quarter Fiscal Year 2023 Financial Results

- Company entered into an Asset Purchase Agreement for substantially all of the operating assets of the Clinical Labs division - Enzo Life Sciences...